Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | DEF 14A: Definitive information statements
Aptose Biosciences | 8-K: Aptose Reports Results for the First Quarter 2024
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Aptose Reports Results for the Fourth Quarter and Full Year 2023
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | 8-K: Current report
Aptose Biosciences | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
Aptose Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Aptose Biosciences | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
No Data